See All Slides - tctmd.com

Slides

Presentation TCT 2012

The Clinical Business Model for CTO PCI in the United States: Do Procedure Time, Reimbursement, and Costs Preclude Development of CTO PCI Programs?

Presenter: Dimitri Karmpaliotis

October 22, 2012

Presentation TCT 2012

Case 1: PCI in STEMI

Presenter: Alexey Protopopov

October 22, 2012

Presentation TCT 2012

Making PFO Closure the Lowest Risk Interventional Procedure: Devices and Techniques

Presenter: Horst Sievert

October 22, 2012

Presentation TCT 2012

Introduction(14)

Presenter: Sigmund Silber

October 22, 2012

Presentation TCT 2012

Taped Case 2: The Corindus Robotic-Assisted Coronary Angioplasty System

Presenter: Giora Weisz

October 22, 2012

Presentation TCT 2012

From Hardware (Devices) to Software (Information Technology): How the Digital Revolution Will Change Medical Innovation

Presenter: Peter Fitzgerald

October 22, 2012

Presentation TCT 2012

Should Interventionalists Even Assess Post-PCI Biomarkers (CKMB, Troponins, or ECGs)?

Presenter: Allan Jaffe

October 22, 2012

Presentation TCT 2012

Autologous vs. Allogeneic Cardiac Stem Cells: The Allstar Trial

Presenter: Raj Makkar

October 22, 2012

Presentation TCT 2012

Emerging Applications of Nanotechnology for the Diagnosis and Management of Vulnerable Atherosclerotic Plaque

Presenter: David Cormode

October 22, 2012

Presentation TCT 2012

Uses and Utility of IVUS During Bifurcation Stenting

Presenter: Akiko Maehara

October 22, 2012

Advertisement

Slides

The Clinical Business Model for CTO PCI in the United States: Do Procedure Time, Reimbursement, and Costs Preclude Development of CTO PCI Programs?

Case 1: PCI in STEMI

Making PFO Closure the Lowest Risk Interventional Procedure: Devices and Techniques

Introduction(14)

Taped Case 2: The Corindus Robotic-Assisted Coronary Angioplasty System

From Hardware (Devices) to Software (Information Technology): How the Digital Revolution Will Change Medical Innovation

Should Interventionalists Even Assess Post-PCI Biomarkers (CKMB, Troponins, or ECGs)?

Autologous vs. Allogeneic Cardiac Stem Cells: The Allstar Trial

Emerging Applications of Nanotechnology for the Diagnosis and Management of Vulnerable Atherosclerotic Plaque

Uses and Utility of IVUS During Bifurcation Stenting

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content